Will Ocwen Survive Legal Onslaught?

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Just when Ocwen Financial Corp. (NYSE: OCN) thought it had made it out of 2014 alive, reality checked back in. California regulators are currently looking to suspend the company’s mortgage license because Ocwen has failed to provide the state with information that proves it has complied with state laws. The question now is whether the company can survive the legal onslaught that it is facing in California.

According to Tom Dressler, a spokesperson for the California Department of Business Oversight, the agency has attempted to get this information from Ocwen for roughly a year now. However the company has repeatedly failed to comply.

Ocwen is one of the largest providers of mortgage services in the United States, and this would be devastating to its position in California.

Previously, the company reached a comprehensive settlement with the New York Department of Financial Services regarding the recent investigation. Ocwen set aside $100 million for the settlement in its third-quarter financial statement. However, the total charge would be $150 million for the settlement, where each current and former New York borrower whose home was foreclosed will receive $10,000 from the company.

This issue arose in New York when Ocwen was accused of doing nothing to investigate or address the backdating issue when an employee questioned the accuracy of the firm’s letter dating processes and alerted the vice-president of Compliance. Then the department said that Ocwen ignored the problem for five months until the same employee raised the issue again.

Since this first news broke, the company has scrambled to pick up the pieces, and it has not been going well.

Ocwen was devastated in Tuesday’s regular trading session, as shares closed down 36% at $7.77. For the full year 2014, Ocwen was down 72.8%.

The stock has a consensus analyst price target of $23.00 and a 52-week trading range of $7.38 to $55.87.

ALSO READ: The Bullish and Bearish Case for J.P. Morgan and Big Banks in 2015

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618